Telos RX by the Numbers: How Its Peptide-Platform Pricing Stacks Up in 2026

The number that pulls you in is $49. It’s the first thing you see, and it’s technically true — for exactly one month. Look one line down and the Telos RX cost picture spreads out fast: $99 for compounded semaglutide, $116 to $139 for the tirzepatide tiers, and as high as $280–$295 a month once you’re on a longer plan. That spread is the actual story here, and it’s why a plain by-the-numbers look at Telos RX pricing in 2026 is more useful than another star rating. Let’s walk the receipts.

What Telos RX charges, tier by tier

Telos runs on compounded peptides — semaglutide and tirzepatide made in U.S. facilities, prescribed only if a licensed provider signs off. The pricing splits along two lines: which molecule you’re on, and how far ahead you commit. Pay month to month and you see the higher per-month rates. Sign a 6- or 12-month block and the ongoing rate is different again, billed in one bigger charge rather than monthly.

• Compounded semaglutide: from $99/month (a $49 first-month intro rate is the headline)
• Microdosed tirzepatide: about $116/month
• Needle-free oral tirzepatide: about $129/month
• Standard tirzepatide: about $139/month
• 12-month tirzepatide plan: $99 first month, then $280/month, billed every 48 weeks
• 6-month tirzepatide plan: $149 first month, then $295/month, billed every 24 weeks

Read those longer plans carefully. A 12-month plan billed every 48 weeks at $280 isn’t $280 out of your account each month — it’s one large charge covering the block. If you budget by the month, that lump can sting. What you’re buying with the commitment is a lower blended rate and, in theory, fewer chances to quit early.

How Telos RX cost compares to typical GLP-1 telehealth

Here’s the part that matters if you’re shopping around. Telos isn’t the cheapest and isn’t the priciest — it sits mid-pack, and its selling point is packaging every peptide under one care team instead of making you juggle separate services.

Option	Compounded semaglutide	Tirzepatide	Notes
Telos RX	From $99/mo ($49 intro)	$116–$139/mo; $280–$295 on longer plans	One care team, multiple peptides
Typical compounded telehealth	~$99–$199/mo	~$199–$449/mo	Varies widely by dose
Brand-name Wegovy (self-pay)	$349/mo injectable	—	FDA-approved
Brand-name Zepbound (self-pay)	—	$299–$449/mo vials	FDA-approved

So against a self-pay brand like Zepbound at $299–$449, Telos undercuts on the compounded side. Against the cheapest compounding shops, it’s roughly even or a touch higher on tirzepatide. The honest read: you’re not choosing Telos to save the last ten dollars. You’re choosing it because you’d rather have one prescriber managing weight, hormones and recovery than three logins and three invoices.

What the “one care team” model actually buys

The pitch isn’t really about the weight-loss shot in isolation. Telos frames itself as a single prescriber and care team spanning several peptide categories — metabolism, hormones, sexual health, recovery — so you’re not opening a second telehealth account when your goals shift. For someone already thinking past the scale, that consolidation has a dollar value that doesn’t show up on any single line item. Fewer separate consult fees. One medical history on file. One team that already knows your doses.

Whether that’s worth a few dollars over the bargain-basement semaglutide shops depends entirely on how you use it. If tirzepatide is the only thing you’ll ever want, the bundle is wasted on you and a single-drug service is cheaper. If you can see yourself layering in other peptides over a year, the one-team setup starts earning its keep. In practice, the people who get the most out of Telos are the ones who treat it as a standing relationship, not a one-time refill.

The compounded footnote that changes the math

None of Telos’s peptides are FDA-approved products. Compounded semaglutide and tirzepatide are made by a pharmacy, not the drugmaker, and after the FDA declared the semaglutide shortage resolved in February 2025, routine bulk compounding wound down. A compounded GLP-1 can still be prescribed, but a clinician has to decide it’s clinically appropriate for you — Telos states plainly that approval is never automatic or guaranteed. That’s the right posture, honestly, and it’s worth weighing against the price. A $99 compounded shot and a $349 FDA-approved pen aren’t the same purchase, even if the active ingredient is.

For context on why any of this is a market at all: roughly 42% of U.S. adults meet the clinical definition of obesity, and most weight-loss prescriptions still aren’t covered by insurance. Cash-pay platforms like Telos exist to fill that exact gap.

Is the Telos RX price worth it?

If you only want a cheap compounded shot and nothing else, you can match or beat Telos elsewhere. Where the money makes sense is the bundled care: one team across semaglutide, tirzepatide, and the hormone and recovery peptides, with a 4.9 Trustpilot record and a LegitScript seal doing the trust-signal work. We’d have liked the full price grid on the homepage instead of a $49 hook that resets after 30 days — that intro rate does more marketing than informing. Go in reading the second-month number, not the first.

Frequently asked questions

How much does Telos RX actually cost per month?

Compounded semaglutide starts at $99/month after a $49 first-month intro. Tirzepatide runs about $116–$139/month on standard plans, and $280–$295/month on the 6- and 12-month plans, where you’re billed in one block rather than monthly. Your real cost depends on the peptide and the commitment length.

Why is the $49 price so much lower than everything else?

Because it’s a first-month introductory rate, not the ongoing price. After that first 30 days, semaglutide steps up to $99 and tirzepatide to its tier price. Budget off the second-month number, not the headline.

Are Telos RX medications FDA-approved?

No. They’re compounded semaglutide and tirzepatide, made in U.S. pharmacies and prescribed only if a licensed provider approves. Compounded GLP-1s are not FDA-approved products, and approval for you specifically is at the prescriber’s discretion.

Is Telos RX cheaper than Wegovy or Zepbound?

On the compounded side, yes — $99–$139/month undercuts self-pay Wegovy at $349 and Zepbound at $299–$449. The tradeoff is that the brands are FDA-approved and Telos’s peptides are not, so it’s a price-versus-approval decision, not just a cheaper-or-not one.